Reports Q1 revenue $204.58M, consensus $200.03M. “Our first quarter results reflect revenue growth and improved adjusted operating income and cash flow,” said Tim Herbert, Chairman and CEO of Inspire Medical (INSP) Systems. “We remain focused on the factors within our control, including prioritizing revenue-generating activities and maintaining disciplined cost management, while continuing targeted investments to support long-term growth and we believe these actions position the Company well in both the near and long term.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- INSP Upcoming Earnings Report: What to Expect?
- Inspire Medical price target lowered to $64 from $70 at Truist
- Inspire Medical price target lowered to $56 from $68 at RBC Capital
- Inspire Medical price target lowered to $70 from $85 at Mizuho
- Inspire Medical price target lowered to $70 from $85 at Stifel